CXCL8 and cystic fibrosis: Fluvastatin was four times more potent in inhibiting LPS-induced IL-8 secretion in whole blood from CF patients than in healthy volunteers, with respective IC50 values being 4.6±1.0 μM and 19.1±7.4 μM (Table 2).